CytoReason Collaborates With Sanofi, Using Its AI Technology to Gain Better Understanding of Disease…
The Focus of the Project Is to Tackle Asthma, a Major Chronic Condition Affecting More Than 340 Million People Globally
CytoReason, an AI…